These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 14763662
1. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Karter Y, Curgunlu A, Altinişik S, Ertürk N, Vehid S, Mihmanli I, Ayan F, Kutlu A, Arat A, Oztürk E, Erdine S. Blood Press; 2003; 12(5-6):307-13. PubMed ID: 14763662 [Abstract] [Full Text] [Related]
3. Hyperhomocysteinemia: an additional risk factor in white coat hypertension. Curgunlu A, Karter Y, Uzun H, Aydin S, Ertürk N, Vehid S, Simsek G, Kutlu A, Oztürk E, Erdine S. Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808 [Abstract] [Full Text] [Related]
4. Differences in behavior profile between normotensive subjects and patients with white-coat and sustained hypertension. Coelho R, Santos A, Ribeiro L, Gama G, Prata J, Barros H, Polónia J. J Psychosom Res; 1999 Jan; 46(1):15-27. PubMed ID: 10088978 [Abstract] [Full Text] [Related]
6. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, Giandalia M, Geraci C, Buscemi S, Cerasola G. J Hum Hypertens; 2007 Nov; 21(11):854-60. PubMed ID: 17541385 [Abstract] [Full Text] [Related]
7. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. Páll D, Juhász M, Lengyel S, Molnár C, Paragh G, Fülesdi B, Katona E. J Hypertens; 2010 Oct; 28(10):2139-44. PubMed ID: 20616755 [Abstract] [Full Text] [Related]
8. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. Gustavsen PH, Høegholm A, Bang LE, Kristensen KS. J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724 [Abstract] [Full Text] [Related]
13. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, Pauletto P. Hypertension; 2008 May; 51(5):1300-5. PubMed ID: 18378860 [Abstract] [Full Text] [Related]
14. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G, Mattarei M, Cozzutti E, Gregori S, Mormino P, Pessina AC. J Hypertens; 1998 Jul; 16(7):977-84. PubMed ID: 9794738 [Abstract] [Full Text] [Related]
18. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, Pessina AC. Hypertension; 1998 Jan; 31(1):57-63. PubMed ID: 9449391 [Abstract] [Full Text] [Related]
19. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polónia J. Blood Press Monit; 2000 Feb; 5(1):11-7. PubMed ID: 10804446 [Abstract] [Full Text] [Related]